Biomednewsbreaks - Annovis Bio Inc. (NYSE: ANVS) Enrolls First Patients In Phase 3 Alzheimer's Trial
Annovis Bio (NYSE: ANVS) announced that the first two patients have been enrolled in its pivotal Phase 3 trial evaluating buntanetap for early Alzhe ...